Aurora Kinase C Market Share, Definition, Treatment, Symptoms 2016 Aurora Kinase C Market | Page 2

- The report covers pipeline products based on various stages of development ranging from pre-registration till
discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description,
descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or
Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) targeted therapeutics and enlists all their major and
minor projects
- The report assesses Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein
Kinase Aurora-C or EC 2.7.11.1) targeted therapeutics based on mechanism of action (MoA), route of
administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase
13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) targeted therapeutics
Buy a Sample Copy of This Report @ http://www.radiantinsights.com/research/aurora-kinase-c-aurora3/request-sample
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) Overview 6
Therapeutics Development 7
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) - Products under Development by Stage of Development 7
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) - Products under Development by Therapy Area 8
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) - Products under Development by Indication 9
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) - Pipeline Products Glance 10
Late Stage Products 10
Early Stage Products 11
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or
EC 2.7.11.1) - Products under Development by Companies 12
Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C o r
EC 2.7.11.1) - Therapeutics Assessment 14
Assessment by Monotherapy/Combination Products 14
Assessment by Mechanism of Action 15
View Full Report with TOC @ http://www.radiantinsights.com/research/aurora-kinase-c-aurora-3
About Us:
Radiant Insights Inc. is a platform for companies looking to meet their market research and business intelligence
requirements. We assist and facilitate organizations and individuals procure market research reports, helping them
in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries
and a host of micro markets. In addition to over extensive database of reports, our experienced research
coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research
solutions.